3 Cannabis Stocks to Add on the Dip

Stocks like Village Farms International Inc. (TSX:VFF)(NASDAQ:VFF) have retreated from soaring valuations. This means investors can start thinking about re-entry this spring.

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

In early February I warned investors about valuations in the cannabis sector. A report from Canadian Imperial Bank of Commerce analysts had driven up the stock price of some key players in the industry, which had coincided with a broader upward trend for the TSX Index. Several of these top stocks have retreated since early-to-mid February. Does that mean it’s worth jumping in right now?

Cronos Group (TSX:CRON)(NASDAQ:CRON)

Cronos Group is a Toronto-based cannabis company. Shares have climbed 56.7% in 2019 as of clos on April 11. The stock has surged 182% from the prior year.

The CIBC report touted Cronos Group as one of its forecasted winners in the global cannabis market scramble. It also touted Canopy Growth as a potential “titan” going forward. Cronos Group made a big splash after announcing its partnership with Altria, a U.S.-based producer and marketer of tobacco, cigarettes, and related products.

Cronos is moving quickly to expand its production, mirroring the push by its peers in the industry. Revenues jumped to $5.6 million in the third quarter of fiscal 2019 compared to $1.6 million in the prior year. The stock last had an RSI of 35 as of close on April 11, putting it close to oversold territory.

Green Organic Dutchman (TSX:TGOD)

The Green Organic Dutchman is a cannabinoid-based research and development company headquartered in Mississauga. Shares of Green Organic Dutchman have climbed 69.5% in 2019 as of close on April 11. The stock is up 7.2% from the prior year. Shares have more than halved since reaching an all-time high of $10.24 in the early fall of 2018.

The company released its year-end results for 2018 on March 19. Green Organic Dutchman finished the year with over $260 million in cash and restricted cash and announced revenues of $1.9 million in Q4 2018. It announced that it had increased its planned annual production capacity to 219,000 kilograms as it has accelerated its construction spending at key locations.

Green Organic Dutchman is trading at the low end of its 52-week range. The stock last had an RSI of 44, which puts it in neutral territory. Value investors may want to wait on the sidelines and jump on a more favourable entry point for this volatile stock.

Village Farms International (TSX:VFF)(NASDAQ:VFF)

Village Farms is a British Columbia-based company that owns and operates greenhouse and agricultural facilities. Its foray into the cannabis sector sparked a surge for the stock as its boasts impressive infrastructure that will support quick expansion. Shares have soared over 290% in 2019 as of close on April 11.

In early March I’d warned investors not to burn themselves with this hot stock. Village Farms would go on to hit an all-time high of $24.25 in mid-March, but shares have fallen in late March and early April. The stock is down 28% from its March high. Sales shrank year-over-year at Village Farms in 2018, but it has scored supply agreements with key partners, including the Ontario Cannabis Retail Corporation, which positions it for big growth going forward.

The stock had an RSI of 46 as of close on April 11. Shares were firmly in overbought territory from late January on through most of March. Village Farms has time to exhale, but its potential is still very encouraging and growth investors should think about picking out entry points this spring.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned. The Motley Fool owns shares of Village Farms International, Inc.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »